Tiagabine for the Treatment of Cocaine Dependence - 1

Completed · Phase 2

Conditions studied: Cocaine-Related Disorders

In brief

The purpose of this study is to assess tiagabine for the treatment of cocaine dependence.

Key facts

Study ID

NCT00086255

Run by

National Institute on Drug Abuse (NIDA)

People needed

140

Starts

2002-10-01

Expected to finish

2004-06-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be at least 18 years of age and be seeking treatment for cocaine dependence. Have the ability to understand, and having understood, provide written informed consent. If female, agree to use a method of birth control as indicated by the clinician. Please contact the participating site in your area for more information.

You may not qualify if…

• Please contact the participating site in your area for more information.

Where it is running

• Boston University Medical Center — Boston, Massachusetts, United States
• Cincinnati VA Medical Center — Cincinnati, Ohio, United States
• Dayton VA Medical Center — Dayton, Ohio, United States
• University of Texas Hlth Sci Ctr Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.